How do you want your Singulair be delivered? Choose here!

Merck & Co. Inc. is coming back.
Two years ago, the company was reeling from its failed pain reliever, Vioxx, and from the impending loss of one of its most profitable drugs. Analysts were openly skeptical about the company's prospects.
But yesterday, Merck reported a 62 percent rise in net income for the third quarter, fueled by a doubling…